TWI522113B - 用以製備活性組份顆粒之新穎方法,及製得之顆粒 - Google Patents

用以製備活性組份顆粒之新穎方法,及製得之顆粒 Download PDF

Info

Publication number
TWI522113B
TWI522113B TW098138860A TW98138860A TWI522113B TW I522113 B TWI522113 B TW I522113B TW 098138860 A TW098138860 A TW 098138860A TW 98138860 A TW98138860 A TW 98138860A TW I522113 B TWI522113 B TW I522113B
Authority
TW
Taiwan
Prior art keywords
particles
granule
core
granules
coating
Prior art date
Application number
TW098138860A
Other languages
English (en)
Chinese (zh)
Other versions
TW201029667A (en
Inventor
克里斯多夫 魯龐
巴斯卡 薩伯里
Original Assignee
戴伯瑞蓋斯合夥製藥
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40348849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TWI522113(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 戴伯瑞蓋斯合夥製藥 filed Critical 戴伯瑞蓋斯合夥製藥
Publication of TW201029667A publication Critical patent/TW201029667A/zh
Application granted granted Critical
Publication of TWI522113B publication Critical patent/TWI522113B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fertilizers (AREA)
  • Glanulating (AREA)
  • Seasonings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW098138860A 2008-11-14 2009-11-16 用以製備活性組份顆粒之新穎方法,及製得之顆粒 TWI522113B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0857764A FR2938432B1 (fr) 2008-11-14 2008-11-14 Nouveau procede de preparation de granules de principes actifs, et granules tels qu'obtenus

Publications (2)

Publication Number Publication Date
TW201029667A TW201029667A (en) 2010-08-16
TWI522113B true TWI522113B (zh) 2016-02-21

Family

ID=40348849

Family Applications (1)

Application Number Title Priority Date Filing Date
TW098138860A TWI522113B (zh) 2008-11-14 2009-11-16 用以製備活性組份顆粒之新穎方法,及製得之顆粒

Country Status (25)

Country Link
US (1) US20110280945A1 (cg-RX-API-DMAC7.html)
EP (1) EP2349226A1 (cg-RX-API-DMAC7.html)
JP (1) JP5608681B2 (cg-RX-API-DMAC7.html)
KR (1) KR101585705B1 (cg-RX-API-DMAC7.html)
CN (1) CN102223879A (cg-RX-API-DMAC7.html)
AR (1) AR074330A1 (cg-RX-API-DMAC7.html)
AU (1) AU2009315449B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0916019A2 (cg-RX-API-DMAC7.html)
CA (1) CA2743753A1 (cg-RX-API-DMAC7.html)
CL (1) CL2011001115A1 (cg-RX-API-DMAC7.html)
CO (1) CO6382108A2 (cg-RX-API-DMAC7.html)
CU (1) CU20110107A7 (cg-RX-API-DMAC7.html)
EA (1) EA201100757A1 (cg-RX-API-DMAC7.html)
FR (1) FR2938432B1 (cg-RX-API-DMAC7.html)
IL (1) IL212850A0 (cg-RX-API-DMAC7.html)
MA (1) MA32789B1 (cg-RX-API-DMAC7.html)
MX (1) MX2011005072A (cg-RX-API-DMAC7.html)
NZ (1) NZ592857A (cg-RX-API-DMAC7.html)
PE (1) PE20110945A1 (cg-RX-API-DMAC7.html)
SG (1) SG195651A1 (cg-RX-API-DMAC7.html)
TN (1) TN2011000235A1 (cg-RX-API-DMAC7.html)
TW (1) TWI522113B (cg-RX-API-DMAC7.html)
UA (1) UA103781C2 (cg-RX-API-DMAC7.html)
WO (1) WO2010055268A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201103543B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2971422B1 (fr) * 2011-02-11 2016-05-20 Debregeas Et Associes Pharma Granules d'acide gamma-hydroxybutyrique
US20140127296A1 (en) * 2012-11-05 2014-05-08 Kenneth John Tibbs Pharmaceutical preparation and method for treatment of diabetes
US9241956B2 (en) * 2012-11-05 2016-01-26 Kenneth John Tibbs Pharmaceutical preparation and method for treatment of diabetes
US11058635B1 (en) * 2020-10-15 2021-07-13 King Abdulaziz University Oral administration of 5-FU in a gelling nanosuspension for targeted delivery to treat colorectal cancers
KR20240157168A (ko) * 2023-04-24 2024-11-01 주식회사 케이티앤지 바인더를 사용하는 파우치 충진 물질의 제조 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6327424A (ja) * 1986-07-17 1988-02-05 Shionogi & Co Ltd 徐放性製剤およびその製造法
JP2820829B2 (ja) * 1991-03-07 1998-11-05 武田薬品工業株式会社 有核散剤およびその製造方法
JPH08310969A (ja) * 1995-05-22 1996-11-26 Lion Corp 固形薬品組成物及びその製造方法
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
JP2002544220A (ja) * 1999-05-17 2002-12-24 デー.ベー.エフ. 植物物質を含有する顆粒及びその製造方法
MY148805A (en) * 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
US9247765B2 (en) * 2004-01-14 2016-02-02 Omniactive Health Technologies Limited Stable beadlets of lipophilic nutrients
FR2880541B1 (fr) * 2005-01-10 2008-02-22 Amalric Veret Une nouvelle formule de plantes sous forme de micro-granules de xilitol pour renforcer les effets des plantes et leurs proprietes par une meilleure assimilation
US20060182796A1 (en) * 2005-02-03 2006-08-17 Abrika Pharmaceuticals, Inc. Taste masked pharmaceutical compositions
NZ575171A (en) * 2006-08-31 2012-04-27 Aptalis Pharmatech Inc Drug delivery systems comprising solid solutions of weakly basic drugs
ES2403103T3 (es) * 2007-02-14 2013-05-14 Dainichiseika Color & Chemicals Mfg. Co., Ltd. Agente dispersante para pigmento orgánico y su utilización
US20090004281A1 (en) * 2007-06-26 2009-01-01 Biovail Laboratories International S.R.L. Multiparticulate osmotic delivery system

Also Published As

Publication number Publication date
ZA201103543B (en) 2012-01-25
US20110280945A1 (en) 2011-11-17
EA201100757A1 (ru) 2011-12-30
FR2938432A1 (fr) 2010-05-21
CU20110107A7 (es) 2012-01-31
CN102223879A (zh) 2011-10-19
CO6382108A2 (es) 2012-02-15
JP2012508786A (ja) 2012-04-12
EP2349226A1 (fr) 2011-08-03
AU2009315449B2 (en) 2015-03-26
NZ592857A (en) 2013-07-26
MA32789B1 (fr) 2011-11-01
UA103781C2 (uk) 2013-11-25
SG195651A1 (en) 2013-12-30
KR20110095888A (ko) 2011-08-25
PE20110945A1 (es) 2012-02-01
AR074330A1 (es) 2011-01-05
CA2743753A1 (fr) 2010-05-20
AU2009315449A1 (en) 2010-05-20
CL2011001115A1 (es) 2011-11-11
WO2010055268A1 (fr) 2010-05-20
IL212850A0 (en) 2011-07-31
JP5608681B2 (ja) 2014-10-15
BRPI0916019A2 (pt) 2015-11-10
KR101585705B1 (ko) 2016-01-15
TW201029667A (en) 2010-08-16
FR2938432B1 (fr) 2011-05-20
MX2011005072A (es) 2011-10-03
TN2011000235A1 (fr) 2012-12-17

Similar Documents

Publication Publication Date Title
KR101563390B1 (ko) 감마-하이드록시부티르산을 주성분으로 하는 신규 조성물
RU2428176C2 (ru) Системы доставки лекарственного средства, содержащие слабоосновные лекарственные средства и органические кислоты
CN103211779B (zh) 包含弱碱性选择性5-羟色胺5-ht3阻断剂和有机酸的药物递送系统
CN101977593B (zh) 包含弱碱性药物以及有机酸的给药系统
JPS61257917A (ja) 複数回の放出を行なう製剤
KR20110008036A (ko) 약 염기성 약물 및 제어 방출 제형을 포함하는 조성물
US20160271124A1 (en) Formulations containing nalbuphine and uses thereof
EP3981390B1 (en) Lacosamide pharmaceutical composition and pharmaceutical preparation thereof
JP3645816B2 (ja) ロラタジン及びプソイドエフェドリンを含有する医薬カプセル組成物
JP5608681B2 (ja) 活性成分の粒状物質を製造する新規の方法、及びそれにより得られた粒状物質
CN1713896B (zh) 球形体、其制备方法以及药物组合物
CA2647765A1 (en) Coated formulations
CN102247366A (zh) 包括含依那普利或依那普利-酸加成盐的速释微丸和含非洛地平的缓释微丸的药物组合物
US8252312B1 (en) Oral solid composition comprising a lipid absorption inhibitor
CN114425046A (zh) 一种盐酸地尔硫卓缓释胶囊
CN102068418A (zh) 索法酮缓释微丸胶囊制剂及其制备方法
WO2005016317A1 (en) Process for manufacture of extended release pellets containing diltiazem hci
KR20150141383A (ko) 슈도에페드린을 함유하는 방출조절 펠렛 조성물

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees